Clinical trial · Observational
A Multi-center Prospective Study on the Oncological and Reproductive Outcomes and Quality of Life in Young Woman After Fertility-sparing Treatment of Endometrial Cancer and Endometrial Intraepithelial Hyperplasia
NCT06745427CI-TRIAL-00083962PreFerEC/EINnot yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
We will investigate the safety and efficiency of fertility-sapring treatment in ypung women witg endometrial cancer and endometrial intraepithelial hyperplasia
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
| Endometrial Intraepithelial Neoplasia | Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | ALIAS | 0.90 |
| Fertility-sparing Surgery | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Relaps of endometrial cancer or EIN after fertility-sparing treatment
- timeFrame
- from enrollment to 2 years after fertility-sparing treatment
- description
- Relaps of endometrial cancer or EIN after fertility-sparing treatment
Secondary outcomes (1)
- measure
- Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN
- timeFrame
- From start of study to 2 years after fertility-sparing treatment
- description
- Live birth rate in women that has been treated with fertility-sparing treatment for EC or EIN
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Fertility sparing treatment of EC and EIN. * 18-45 Years old * From start study (Jan 2025 - end study Jan 2028) * All centras in Sweden Exclusion Criteria: * Not English och Swedish speaking
References
Publications (0)
Data not yet available
No reference posted for this study.